Skip to main content
Top
Published in: Respiratory Research 1/2011

Open Access 01-12-2011 | Research

Lack of cathepsin activities alter or prevent the development of lung granulomas in a mouse model of sarcoidosis

Authors: Andriy O Samokhin, Jacques Yves Gauthier, M David Percival, Dieter Brömme

Published in: Respiratory Research | Issue 1/2011

Login to get access

Abstract

Background

Remodeling of lung tissues during the process of granuloma formation requires significant restructuring of the extra-cellular matrix and cathepsins K, L and S are among the strongest extra-cellular matrix degrading enzymes. Cathepsin K is highly expressed in various pathological granulomatous infiltrates and all three enzymes in their active form are detected in bronchoalveolar lavage fluids from patients with sarcoidosis. Granulomatous inflammation is driven by T-cell response and cathepsins S and L are actively involved in the regulation of antigen presentation and T-cell selection. Here, we show that the disruption of the activities of cathepsins K, L, or S affects the development of lung granulomas in a mouse model of sarcoidosis.

Methods

Apolipoprotein E-deficient mice lacking cathepsin K or L were fed Paigen diet for 16 weeks and lungs were analyzed and compared with their cathepsin-expressing littermates. The role of cathepsin S in the development of granulomas was evaluated using mice treated for 8 weeks with a potent and selective cathepsin S inhibitor.

Results

When compared to wild-type litters, more cathepsin K-deficient mice had lung granulomas, but individually affected mice developed smaller granulomas that were present in lower numbers. The absence of cathepsin K increased the number of multinucleated giant cells and the collagen content in granulomas. Cathepsin L deficiency resulted in decreased size and number of lung granulomas. Apoe-/- mice treated with a selective cathepsin S inhibitor did not develop lung granulomas and only individual epithelioid cells were observed.

Conclusions

Cathepsin K deficiency affected mostly the occurrence and composition of lung granulomas, whereas cathepsin L deficiency significantly reduced their number and cathepsin S inhibition prevented the formation of granulomas.
Appendix
Available only for authorised users
Literature
2.
go back to reference Buhling F, Waldburg N, Reisenauer A, Heimburg A, Golpon H, Welte T: Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation. Eur Respir J. 2004, 23 (4): 620-628. 10.1183/09031936.04.00105304.CrossRefPubMed Buhling F, Waldburg N, Reisenauer A, Heimburg A, Golpon H, Welte T: Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation. Eur Respir J. 2004, 23 (4): 620-628. 10.1183/09031936.04.00105304.CrossRefPubMed
3.
go back to reference Hirakawa H, Pierce RA, Bingol-Karakoc G, Karaaslan C, Weng M, Shi GP, Saad A, Weber E, Mariani TJ, Starcher B, et al: Cathepsin S deficiency confers protection from neonatal hyperoxia-induced lung injury. Am J Respir Crit Care Med. 2007, 176 (8): 778-785. 10.1164/rccm.200704-519OC.CrossRefPubMedPubMedCentral Hirakawa H, Pierce RA, Bingol-Karakoc G, Karaaslan C, Weng M, Shi GP, Saad A, Weber E, Mariani TJ, Starcher B, et al: Cathepsin S deficiency confers protection from neonatal hyperoxia-induced lung injury. Am J Respir Crit Care Med. 2007, 176 (8): 778-785. 10.1164/rccm.200704-519OC.CrossRefPubMedPubMedCentral
4.
go back to reference Williams AS, Eynott PR, Leung SY, Nath P, Jupp R, De Sanctis GT, Resnick R, Adcock IM, Chung KF: Role of cathepsin S in ozone-induced airway hyperresponsiveness and inflammation. Pulm Pharmacol Ther. 2009, 22 (1): 27-32. 10.1016/j.pupt.2008.11.002.CrossRefPubMed Williams AS, Eynott PR, Leung SY, Nath P, Jupp R, De Sanctis GT, Resnick R, Adcock IM, Chung KF: Role of cathepsin S in ozone-induced airway hyperresponsiveness and inflammation. Pulm Pharmacol Ther. 2009, 22 (1): 27-32. 10.1016/j.pupt.2008.11.002.CrossRefPubMed
5.
go back to reference Veillard F, Lecaille F, Lalmanach G: Lung cysteine cathepsins: intruders or unorthodox contributors to the kallikrein-kinin system?. Int J Biochem Cell Biol. 2008, 40 (6-7): 1079-1094. 10.1016/j.biocel.2007.10.030.CrossRefPubMed Veillard F, Lecaille F, Lalmanach G: Lung cysteine cathepsins: intruders or unorthodox contributors to the kallikrein-kinin system?. Int J Biochem Cell Biol. 2008, 40 (6-7): 1079-1094. 10.1016/j.biocel.2007.10.030.CrossRefPubMed
6.
go back to reference Samokhin AO, Buhling F, Theissig F, Bromme D: ApoE-deficient mice on cholate-containing high-fat diet reveal a pathology similar to lung sarcoidosis. Am J Pathol. 2010, 176 (3): 1148-1156. 10.2353/ajpath.2010.090857.CrossRefPubMedPubMedCentral Samokhin AO, Buhling F, Theissig F, Bromme D: ApoE-deficient mice on cholate-containing high-fat diet reveal a pathology similar to lung sarcoidosis. Am J Pathol. 2010, 176 (3): 1148-1156. 10.2353/ajpath.2010.090857.CrossRefPubMedPubMedCentral
7.
go back to reference Lynch JP, Ma YL, Koss MN, White ES: Pulmonary sarcoidosis. Semin Respir Crit Care Med. 2007, 28 (1): 53-74. 10.1055/s-2007-970333.CrossRefPubMed Lynch JP, Ma YL, Koss MN, White ES: Pulmonary sarcoidosis. Semin Respir Crit Care Med. 2007, 28 (1): 53-74. 10.1055/s-2007-970333.CrossRefPubMed
8.
go back to reference Sharma OP: Sarcoidosis: a historical perspective. Clin Dermatol. 2007, 25 (3): 232-241. 10.1016/j.clindermatol.2007.03.013.CrossRefPubMed Sharma OP: Sarcoidosis: a historical perspective. Clin Dermatol. 2007, 25 (3): 232-241. 10.1016/j.clindermatol.2007.03.013.CrossRefPubMed
9.
go back to reference Lalmanach G, Diot E, Godat E, Lecaille F, Herve-Grepinet V: Cysteine cathepsins and caspases in silicosis. Biol Chem. 2006, 387 (7): 863-870. 10.1515/BC.2006.109.CrossRefPubMed Lalmanach G, Diot E, Godat E, Lecaille F, Herve-Grepinet V: Cysteine cathepsins and caspases in silicosis. Biol Chem. 2006, 387 (7): 863-870. 10.1515/BC.2006.109.CrossRefPubMed
10.
go back to reference Diaz A, Willis AC, Sim RB: Expression of the proteinase specialized in bone resorption, cathepsin K, in granulomatous inflammation. Mol Med. 2000, 6 (8): 648-659.PubMedPubMedCentral Diaz A, Willis AC, Sim RB: Expression of the proteinase specialized in bone resorption, cathepsin K, in granulomatous inflammation. Mol Med. 2000, 6 (8): 648-659.PubMedPubMedCentral
11.
go back to reference Buhling F, Reisenauer A, Gerber A, Kruger S, Weber E, Bromme D, Roessner A, Ansorge S, Welte T, Rocken C: Cathepsin K--a marker of macrophage differentiation?. J Pathol. 2001, 195 (3): 375-382. 10.1002/path.959.CrossRefPubMed Buhling F, Reisenauer A, Gerber A, Kruger S, Weber E, Bromme D, Roessner A, Ansorge S, Welte T, Rocken C: Cathepsin K--a marker of macrophage differentiation?. J Pathol. 2001, 195 (3): 375-382. 10.1002/path.959.CrossRefPubMed
12.
go back to reference Chilosi AM, Brizzolara D, Lami L, Pizzoli C, Gasperini F, Pecini C, Cipriani P, Zoccolotti P: Reading and Spelling Disabilities in Children With and Without a History of Early Language Delay: A Neuropsychological and Linguistic Study. Child Neuropsychol. 2009, 1-23. Chilosi AM, Brizzolara D, Lami L, Pizzoli C, Gasperini F, Pecini C, Cipriani P, Zoccolotti P: Reading and Spelling Disabilities in Children With and Without a History of Early Language Delay: A Neuropsychological and Linguistic Study. Child Neuropsychol. 2009, 1-23.
13.
go back to reference Serveau-Avesque C, Martino MF, Herve-Grepinet V, Hazouard E, Gauthier F, Diot E, Lalmanach G: Active cathepsins B, H, K, L and S in human inflammatory bronchoalveolar lavage fluids. Biol Cell. 2006, 98 (1): 15-22. 10.1042/BC20040512.CrossRefPubMed Serveau-Avesque C, Martino MF, Herve-Grepinet V, Hazouard E, Gauthier F, Diot E, Lalmanach G: Active cathepsins B, H, K, L and S in human inflammatory bronchoalveolar lavage fluids. Biol Cell. 2006, 98 (1): 15-22. 10.1042/BC20040512.CrossRefPubMed
14.
go back to reference Shi GP, Munger JS, Meara JP, Rich DH, Chapman HA: Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J Biol Chem. 1992, 267: 7258-7262.PubMed Shi GP, Munger JS, Meara JP, Rich DH, Chapman HA: Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J Biol Chem. 1992, 267: 7258-7262.PubMed
15.
go back to reference Honey K, Rudensky AY: Lysosomal cysteine proteases regulate antigen presentation. Nat Rev Immunol. 2003, 3 (6): 472-482. 10.1038/nri1110.CrossRefPubMed Honey K, Rudensky AY: Lysosomal cysteine proteases regulate antigen presentation. Nat Rev Immunol. 2003, 3 (6): 472-482. 10.1038/nri1110.CrossRefPubMed
16.
go back to reference Hsing LC, Rudensky AY: The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol Rev. 2005, 207: 229-241. 10.1111/j.0105-2896.2005.00310.x.CrossRefPubMed Hsing LC, Rudensky AY: The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol Rev. 2005, 207: 229-241. 10.1111/j.0105-2896.2005.00310.x.CrossRefPubMed
17.
go back to reference Nakagawa T, Roth W, Wong P, Nelson A, Farr A, Deussing J, Villadangos JA, Ploegh H, Peters C, Rudensky AY: Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science. 1998, 280: 450-453. 10.1126/science.280.5362.450.CrossRefPubMed Nakagawa T, Roth W, Wong P, Nelson A, Farr A, Deussing J, Villadangos JA, Ploegh H, Peters C, Rudensky AY: Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science. 1998, 280: 450-453. 10.1126/science.280.5362.450.CrossRefPubMed
19.
go back to reference Zissel G, Prasse A, Muller-Quernheim J: Sarcoidosis--immunopathogenetic concepts. Semin Respir Crit Care Med. 2007, 28 (1): 3-14. 10.1055/s-2007-970329.CrossRefPubMed Zissel G, Prasse A, Muller-Quernheim J: Sarcoidosis--immunopathogenetic concepts. Semin Respir Crit Care Med. 2007, 28 (1): 3-14. 10.1055/s-2007-970329.CrossRefPubMed
20.
go back to reference Gerke AK, Hunninghake G: The immunology of sarcoidosis. Clin Chest Med. 2008, 29 (3): 379-390. 10.1016/j.ccm.2008.03.014. viiCrossRefPubMed Gerke AK, Hunninghake G: The immunology of sarcoidosis. Clin Chest Med. 2008, 29 (3): 379-390. 10.1016/j.ccm.2008.03.014. viiCrossRefPubMed
21.
go back to reference Noor A, Knox KS: Immunopathogenesis of sarcoidosis. Clin Dermatol. 2007, 25 (3): 250-258. 10.1016/j.clindermatol.2007.03.002.CrossRefPubMed Noor A, Knox KS: Immunopathogenesis of sarcoidosis. Clin Dermatol. 2007, 25 (3): 250-258. 10.1016/j.clindermatol.2007.03.002.CrossRefPubMed
22.
go back to reference Samokhin AO, Wong A, Saftig P, Bromme D: Role of cathepsin K in structural changes in brachiocephalic artery during progression of atherosclerosis in apoE-deficient mice. Atherosclerosis. 2008, 200 (1): 58-68. 10.1016/j.atherosclerosis.2007.12.047.CrossRefPubMed Samokhin AO, Wong A, Saftig P, Bromme D: Role of cathepsin K in structural changes in brachiocephalic artery during progression of atherosclerosis in apoE-deficient mice. Atherosclerosis. 2008, 200 (1): 58-68. 10.1016/j.atherosclerosis.2007.12.047.CrossRefPubMed
23.
go back to reference Saftig P, Wehmeyer O, Hunziker E, Jones S, Boyde A, Rommerskirch W, von Figura K: Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin K-deficient mice. Proc Natl Acad Sci USA. 1998, 95: 13453-13458. 10.1073/pnas.95.23.13453.CrossRefPubMedPubMedCentral Saftig P, Wehmeyer O, Hunziker E, Jones S, Boyde A, Rommerskirch W, von Figura K: Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin K-deficient mice. Proc Natl Acad Sci USA. 1998, 95: 13453-13458. 10.1073/pnas.95.23.13453.CrossRefPubMedPubMedCentral
24.
go back to reference Buhling F, Rocken C, Brasch F, Hartig R, Yasuda Y, Saftig P, Bromme D, Welte T: Pivotal role of cathepsin K in lung fibrosis. Am J Pathol. 2004, 164 (6): 2203-2216.CrossRefPubMedPubMedCentral Buhling F, Rocken C, Brasch F, Hartig R, Yasuda Y, Saftig P, Bromme D, Welte T: Pivotal role of cathepsin K in lung fibrosis. Am J Pathol. 2004, 164 (6): 2203-2216.CrossRefPubMedPubMedCentral
25.
go back to reference Roth W, Deussing J, Botchkarev VA, Pauly-Evers M, Saftig P, Hafner A, Schmidt P, Schmahl W, Scherer J, Anton-Lamprecht I, et al: Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling. Faseb J. 2000, 14 (13): 2075-2086. 10.1096/fj.99-0970com.CrossRefPubMed Roth W, Deussing J, Botchkarev VA, Pauly-Evers M, Saftig P, Hafner A, Schmidt P, Schmahl W, Scherer J, Anton-Lamprecht I, et al: Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling. Faseb J. 2000, 14 (13): 2075-2086. 10.1096/fj.99-0970com.CrossRefPubMed
26.
go back to reference Gauthier JY, Black WC, Courchesne I, Cromlish W, Desmarais S, Houle R, Lamontagne S, Li CS, Masse F, McKay DJ, et al: The identification of potent, selective, and bioavailable cathepsin S inhibitors. Bioorg Med Chem Lett. 2007, 17 (17): 4929-4933. 10.1016/j.bmcl.2007.06.023.CrossRefPubMed Gauthier JY, Black WC, Courchesne I, Cromlish W, Desmarais S, Houle R, Lamontagne S, Li CS, Masse F, McKay DJ, et al: The identification of potent, selective, and bioavailable cathepsin S inhibitors. Bioorg Med Chem Lett. 2007, 17 (17): 4929-4933. 10.1016/j.bmcl.2007.06.023.CrossRefPubMed
27.
go back to reference Xia L, Kilb J, Wex H, Lipyansky A, Breuil V, Stein L, Palmer JT, Dempster DW, Brömme D: Localization of rat cathepsin K in osteoclasts and resorption pits: Inhibition of bone resorption cathepsin K-activity by peptidyl vinyl sulfones. Biol Chem. 1999, 380: 679-687. 10.1515/BC.1999.084.CrossRefPubMed Xia L, Kilb J, Wex H, Lipyansky A, Breuil V, Stein L, Palmer JT, Dempster DW, Brömme D: Localization of rat cathepsin K in osteoclasts and resorption pits: Inhibition of bone resorption cathepsin K-activity by peptidyl vinyl sulfones. Biol Chem. 1999, 380: 679-687. 10.1515/BC.1999.084.CrossRefPubMed
28.
go back to reference Kocks JR, Davalos-Misslitz AC, Hintzen G, Ohl L, Forster R: Regulatory T cells interfere with the development of bronchus-associated lymphoid tissue. J Exp Med. 2007, 204 (4): 723-734. 10.1084/jem.20061424.CrossRefPubMedPubMedCentral Kocks JR, Davalos-Misslitz AC, Hintzen G, Ohl L, Forster R: Regulatory T cells interfere with the development of bronchus-associated lymphoid tissue. J Exp Med. 2007, 204 (4): 723-734. 10.1084/jem.20061424.CrossRefPubMedPubMedCentral
29.
go back to reference Riese RJ, Wolf P, Bromme D, Natkin LR, Villadangos JA, Ploegh HL, Chapman HA: Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity. 1996, 4 (4): 357-366. 10.1016/S1074-7613(00)80249-6.CrossRefPubMed Riese RJ, Wolf P, Bromme D, Natkin LR, Villadangos JA, Ploegh HL, Chapman HA: Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity. 1996, 4 (4): 357-366. 10.1016/S1074-7613(00)80249-6.CrossRefPubMed
30.
go back to reference Riese RJ, Mitchell RN, Villadangos JA, Shi GP, Palmer JT, Karp ER, De Sanctis GT, Ploegh HL, Chapman HA: Cathepsin S activity regulates antigen presentation and immunity. J Clin Invest. 1998, 101 (11): 2351-2363. 10.1172/JCI1158.CrossRefPubMedPubMedCentral Riese RJ, Mitchell RN, Villadangos JA, Shi GP, Palmer JT, Karp ER, De Sanctis GT, Ploegh HL, Chapman HA: Cathepsin S activity regulates antigen presentation and immunity. J Clin Invest. 1998, 101 (11): 2351-2363. 10.1172/JCI1158.CrossRefPubMedPubMedCentral
31.
go back to reference Samokhin AO, Wilson S, Nho B, Lizame ML, Musenden OE, Bromme D: Cholate-containing high-fat diet induces the formation of multinucleated giant cells in atherosclerotic plaques of apolipoprotein E-/- mice. Arterioscler Thromb Vasc Biol. 2010, 30 (6): 1166-1173. 10.1161/ATVBAHA.110.203976.CrossRefPubMed Samokhin AO, Wilson S, Nho B, Lizame ML, Musenden OE, Bromme D: Cholate-containing high-fat diet induces the formation of multinucleated giant cells in atherosclerotic plaques of apolipoprotein E-/- mice. Arterioscler Thromb Vasc Biol. 2010, 30 (6): 1166-1173. 10.1161/ATVBAHA.110.203976.CrossRefPubMed
32.
go back to reference Brömme D, Okamoto K, Wang BB, Biroc S: Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme. J Biol Chem. 1996, 271 (4): 2126-2132.CrossRefPubMed Brömme D, Okamoto K, Wang BB, Biroc S: Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme. J Biol Chem. 1996, 271 (4): 2126-2132.CrossRefPubMed
33.
go back to reference Nagai S, Handa T, Ito Y, Ohta K, Tamaya M, Izumi T: Outcome of sarcoidosis. Clin Chest Med. 2008, 29 (3): 565-574. 10.1016/j.ccm.2008.03.006. xCrossRefPubMed Nagai S, Handa T, Ito Y, Ohta K, Tamaya M, Izumi T: Outcome of sarcoidosis. Clin Chest Med. 2008, 29 (3): 565-574. 10.1016/j.ccm.2008.03.006. xCrossRefPubMed
34.
go back to reference van Maarsseveen TC, Vos W, van Diest PJ: Giant cell formation in sarcoidosis: cell fusion or proliferation with non-division?. Clin Exp Immunol. 2009, 155 (3): 476-486. 10.1111/j.1365-2249.2008.03841.x.CrossRefPubMedPubMedCentral van Maarsseveen TC, Vos W, van Diest PJ: Giant cell formation in sarcoidosis: cell fusion or proliferation with non-division?. Clin Exp Immunol. 2009, 155 (3): 476-486. 10.1111/j.1365-2249.2008.03841.x.CrossRefPubMedPubMedCentral
35.
go back to reference Lutgens E, Lutgens SP, Faber BC, Heeneman S, Gijbels MM, de Winther MP, Frederik P, van der Made I, Daugherty A, Sijbers AM, et al: Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation. 2006, 113 (1): 98-107. 10.1161/CIRCULATIONAHA.105.561449.CrossRefPubMed Lutgens E, Lutgens SP, Faber BC, Heeneman S, Gijbels MM, de Winther MP, Frederik P, van der Made I, Daugherty A, Sijbers AM, et al: Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation. 2006, 113 (1): 98-107. 10.1161/CIRCULATIONAHA.105.561449.CrossRefPubMed
36.
go back to reference Lutgens SP, Kisters N, Lutgens E, van Haaften RI, Evelo CT, de Winther MP, Saftig P, Daemen MJ, Heeneman S, Cleutjens KB: Gene profiling of cathepsin K deficiency in atherogenesis: profibrotic but lipogenic. J Pathol. 2006, 210 (3): 334-343. 10.1002/path.2054.CrossRefPubMed Lutgens SP, Kisters N, Lutgens E, van Haaften RI, Evelo CT, de Winther MP, Saftig P, Daemen MJ, Heeneman S, Cleutjens KB: Gene profiling of cathepsin K deficiency in atherogenesis: profibrotic but lipogenic. J Pathol. 2006, 210 (3): 334-343. 10.1002/path.2054.CrossRefPubMed
37.
go back to reference Helming L, Winter J, Gordon S: The scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion. J Cell Sci. 2009, 122 (Pt 4): 453-459. 10.1242/jcs.037200.CrossRefPubMedPubMedCentral Helming L, Winter J, Gordon S: The scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion. J Cell Sci. 2009, 122 (Pt 4): 453-459. 10.1242/jcs.037200.CrossRefPubMedPubMedCentral
38.
go back to reference Nakagawa TY, Brissette WH, Lira PD, Griffiths RJ, Petrushova N, Stock J, McNeish JD, Eastman SE, Howard ED, Clarke SR, et al: Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity. 1999, 10: 207-217. 10.1016/S1074-7613(00)80021-7.CrossRefPubMed Nakagawa TY, Brissette WH, Lira PD, Griffiths RJ, Petrushova N, Stock J, McNeish JD, Eastman SE, Howard ED, Clarke SR, et al: Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity. 1999, 10: 207-217. 10.1016/S1074-7613(00)80021-7.CrossRefPubMed
39.
go back to reference Honey K, Nakagawa T, Peters C, Rudensky A: Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands. J Exp Med. 2002, 195 (10): 1349-1358. 10.1084/jem.20011904.CrossRefPubMedPubMedCentral Honey K, Nakagawa T, Peters C, Rudensky A: Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands. J Exp Med. 2002, 195 (10): 1349-1358. 10.1084/jem.20011904.CrossRefPubMedPubMedCentral
40.
go back to reference Lombardi G, Burzyn D, Mundinano J, Berguer P, Bekinschtein P, Costa H, Castillo LF, Goldman A, Meiss R, Piazzon I, et al: Cathepsin-L influences the expression of extracellular matrix in lymphoid organs and plays a role in the regulation of thymic output and of peripheral T cell number. J Immunol. 2005, 174 (11): 7022-7032.CrossRefPubMed Lombardi G, Burzyn D, Mundinano J, Berguer P, Bekinschtein P, Costa H, Castillo LF, Goldman A, Meiss R, Piazzon I, et al: Cathepsin-L influences the expression of extracellular matrix in lymphoid organs and plays a role in the regulation of thymic output and of peripheral T cell number. J Immunol. 2005, 174 (11): 7022-7032.CrossRefPubMed
Metadata
Title
Lack of cathepsin activities alter or prevent the development of lung granulomas in a mouse model of sarcoidosis
Authors
Andriy O Samokhin
Jacques Yves Gauthier
M David Percival
Dieter Brömme
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2011
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-12-13

Other articles of this Issue 1/2011

Respiratory Research 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine